Market News AIOpen the app

PCSA stock news · Processa Pharmaceuticals, Inc.

Stories about Processa Pharmaceuticals, Inc. (PCSA) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for PCSA

Follow Processa Pharmaceuticals, Inc. (PCSA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PCSA
Free on the App Store and Google Play, or on the web.
  1. Nov 5, 2026, 10:11 AM ET · Market

    Processa Pharmaceuticals sent a letter to shareholders on November 5, 2026.

    Neutral

    Processa reported sending stockholders a letter, but the filing gives no details about it. So it does not change how we read the company.

  2. Oct 12, 2026, 1:15 PM ET · Market

    12 health care stocks are changing a lot during Monday's trading.

    Neutral

    Processa Pharma's shares rose 21.05% to $1.84 per share, but the report gives no company news explaining the move. It does not change the business outlook.

  3. Oct 5, 2026, 7:26 AM ET · Market

    Processa Pharmaceuticals, Inc. shares updates about its purchase of Vidya Therapeutics.

    Neutral

    PCSA filed an update with Vidya's financial statements, business details, and risk information. It adds background but reports no new business change, leaving PCSA's outlook unchanged.